SEC Form 4 · accession 0000921895-16-004207
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Apr 19, 2016
Accepted (ET)
Apr 21, 2016 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 19, 2016 | S | 49,509 | $2.00 | D | 5,652,878 | D | |
| Common Stock | Apr 19, 2016 | S | 7,562 | $2.0001 | D | 5,645,316 | D | |
| Common Stock | Apr 19, 2016 | S | 375 | $2.0025 | D | 5,644,941 | D | |
| Common Stock | Apr 19, 2016 | S | 500 | $2.005 | D | 5,644,441 | D | |
| Common Stock | Apr 19, 2016 | S | 11,751 | $2.01 | D | 5,632,690 | D | |
| Common Stock | Apr 19, 2016 | S | 2,500 | $2.02 | D | 5,630,190 | D | |
| Common Stock | Apr 19, 2016 | S | 2,500 | $2.03 | D | 5,627,690 | D | |
| Common Stock | Apr 19, 2016 | S | 4,800 | $2.04 | D | 5,622,890 | D | |
| Common Stock | Apr 19, 2016 | S | 33,300 | $2.05 | D | 5,589,590 | D | |
| Common Stock | Apr 19, 2016 | S | 300 | $2.0515 | D | 5,589,290 | D | |
| Common Stock | Apr 19, 2016 | S | 18,200 | $2.055 | D | 5,571,090 | D | |
| Common Stock | Apr 19, 2016 | S | 8,633 | $2.06 | D | 5,562,457 | D | |
| Common Stock | Apr 19, 2016 | S | 4,517 | $2.065 | D | 5,557,940 | D | |
| Common Stock | Apr 19, 2016 | S | 2,133 | $2.07 | D | 5,555,807 | D | |
| Common Stock | Apr 19, 2016 | S | 3,420 | $2.0701 | D | 5,552,387 | D | |
| Common Stock | Apr 20, 2016 | S | 600 | $2.00 | D | 5,551,787 | D | |
| Common Stock | Apr 20, 2016 | S | 200 | $2.01 | D | 5,551,587 | D | |
| Common Stock | Apr 20, 2016 | S | 4,000 | $2.02 | D | 5,547,587 | D | |
| Common Stock | Apr 20, 2016 | S | 18,224 | $2.03 | D | 5,529,363 | D | |
| Common Stock | Apr 20, 2016 | S | 10,473 | $2.04 | D | 5,518,890 | D | |
| Common Stock | Apr 21, 2016 | S | 9,300 | $2.04 | D | 5,509,590 | D | |
| Common Stock | Apr 21, 2016 | S | 3,700 | $2.05 | D | 5,505,890 | D |
Table II — derivative securities
No Table II lines on this filing.